Skip to the page

Data / Form D filings / Awakn Life Sciences Corp.

Awakn Life Sciences Corp.: Form D filings

Awakn Life Sciences Corp., a company in Toronto, Ontario, Canada, filed 4 Form D notices with the SEC between 2022 and 2023. The latest, on June 26, 2023, reports $575,000 sold of a $1.2 million offering to 5 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
301-217 QUEEN ST WEST, Toronto, Ontario, Canada, M5V 0
Phone
(416) 270-9566
Industry
Other
Entity type
Corporation
Incorporated in
Ontario, Canada
Year incorporated
2018
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1948724

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 26, 2023New notice$1,158,777$575,000$583,7775Jun 14, 2023sec.gov
May 3, 2023New notice$1,144,807$575,000$569,8072Apr 25, 2023sec.gov
Nov 21, 2022New notice$2,952,526$1,366,214$1,586,3129Nov 16, 2022sec.gov
Sep 28, 2022New notice$284,621$130,152$154,4694Sep 14, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Shaun McNultyExecutive Officer
Jonathan HeldExecutive Officer
Steve PageDirector
George ScorsisDirector
John PapastergiouDirector
Paul CarterDirector
Anthony TennysonExecutive Officer, Director

Every Form D from the week of Jun 26, 2023 · All recent Other filings

Read from SEC EDGAR. Amount sold is what Awakn Life Sciences Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.